Concert Streamlines Genetic Test Prior Authorizations for Clinicians and Patients.

Concert, a healthcare company, is partnering with EviCore by Evernorth to streamline patient access to genetic testing. By aligning their payment policies, coding standards, and authorization guidelines, Concert and EviCore aim to simplify the authorization process for genetic tests, improving efficiency and transparency for health plans, providers, and patients. This collaboration will also ensure accurate billing and payment processes, reducing surprise bills for patients. The solution is expected to be available in mid-2024. [Extracted from the article]

Copyright of Pharma Business Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)